COVID-19: Five things to watch for this week in BC

Masks in schools, COVID in the US and dropping testing requirements to enter Canada are some of the things to keep an eye on

Content item

It’s been almost six weeks since provincial health officer Dr. Bonnie Henry began lifting restrictions aimed at curtailing the spread of COVID-19.

Advertisement 2

Content item

It began on Feb. 15 with the removal of some restrictions on private and public gatherings and then on March 11 face mask rules in most indoor public settings were lifted.

These decisions came as the pandemic entered a third year and as the number of people in hospital with the disease continued to fall.

Here’s five things to watch for this week in BC on the COVID-19 front:


Face mask on a desk in a classroom.
Face mask on a desk in a classroom. Photo by MarianVejcik /Getty Images/iStockphoto

1. Return to school

It will have been just over two weeks since the mask mandate was lifted, which coincided with the start of spring break for kids. So, as of Monday it will be up to each student to decide whether they will continue to wear a mask.

BC’s Safe Schools Coalition has written a letter to the Ministry of Education asking for a return to masking in schools.

Advertisement 3

Content item


A variant of the Omicron COVID-19 variant has appeared across the world.
A variant of the Omicron COVID-19 variant has appeared across the world.

2. Global surge of the Omicron subvariant BA. 2

The Omicron subvariant BA. 2 is continuing to gain ground in the US, China and parts of Europe and Australia.

This subvariant is more infectious than Omicron, so while restrictions are being lifted across the world there remains cause for concern.

China — with its zero-COVID policy — is now dealing with its worst outbreak since the virus emerged in Wuhan in December of 2019.

About 4.25 million people currently have the disease in the UK while a third of European nations, including Germany and France, are seeing a surge in cases.

Even Western Australia — labeled the hermit kingdom because its borders were closed for two years to anyone, including people from other Australian states — is now reporting over 7,000 new cases a day after borders reopened.

Advertisement 4

Content item


A Covid-19 rapid test kit at Three Links Long Term care home Thursday, January 13, 2022.
A Covid-19 rapid test kit at Three Links Long Term care home Thursday, January 13, 2022. Photo by Jason Payne /PNG

3. No more rapid tests needed to get into Canada

Vaccinated travelers will no longer need to show a COVID-19 test to enter Canada as of Friday, April 1.

Incoming tourists and returning Canadians still need to be vaccinated.

Unvaccinated people with exemptions will still need to provide a negative rapid test result or proof of a recent infection to enter Canada.


A boy receives a booster dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at the Central Vaccination Center, inside the Bang Sue Grand Station, in Bangkok, Thailand, January 22, 2022.
A boy receives a booster dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at the Central Vaccination Center, inside the Bang Sue Grand Station, in Bangkok, Thailand, January 22, 2022. Photo by CHALINEE THIRASUPA /REUTERS

4. More data coming out on booster shots

British Columbia’s high vaccination rate was a reason Dr. Henry began lifting restrictions — with 57 per cent of adults having received a booster shot.

A study of 500,000 adults in Israel showed a second booster of the Pfizer vaccine reduced mortality rates compared to people who got one dose.

New data from the UK’s Health Security Agency also shows a second booster dose of COVID-19 vaccine provided strong protection against hospitalization for people aged over 65. The UK is administering fourth doses among vulnerable groups.

Advertisement 5

Content item

Expect more data this week on the usefulness of vaccine booster shots.


Pfizer vaccine for COVID-19.
Pfizer vaccine for COVID-19. Photo by Dado Ruvic /REUTERS

5. Vaccine stocks are plunging

It may seem counterintuitive, but shares in Moderna and Pfizer have been falling.

Following a rapid ascent that began in 2002, Moderna shares have lost almost a third of their value since the beginning of the year amid waning pandemic concerns.

Moderna has signed deals for $21 billion in 2022 vaccine sales and says it will apply for clearance for its COVID-19 vaccine in kids under six.

Among other vaccine makers, BioNTech SE and Novavax Inc. stock have each fallen by at least 51 per cent this year.

Shares could fall again this week if the US government reduces the amount of vaccinations that are distributed for free.

with files from Bloomberg

Advertisement 1

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourages all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Leave a Reply